Those Who Have the Gold Make the Evidence: The Pharmaceutical Industry and Clinical Trials

April 10, 2014, Ontario, Canada

Joel Lexchin, York University
April 10, 2014
Western University, David Chu Centre, Western Student Services Building room 2130

Start Time: 7:00 pm EST
End Time: 8:30 pm EST
For information on parking at Western, please click here.
This event will be streamed live online.

Join us this April for a talk by Joel Lexchin of York University. In his talk Lexchin will discus how funding from pharmaceutical companies introduces bias into drug research.

Abstract
Pharmaceutical companies fund the bulk of clinical research and this funding can introduce biases into the research through methods such as influencing the choice of standards of comparison, only publishing positive trials, reinterpreting data submitted to regulatory agencies, ghostwriting, and the use of “seeding” trials. There is no evidence that any of the measures introduced so far have stopped this bias and it’s not clear that they have even slowed down the process. What is needed is a paradigm change in the relationship between pharmaceutical companies and the conduct and reporting of clinical trials.

Biography
Dr. Lexchin is an emergency physician at The University Health Network and a Professor in the School of Health Policy and Management at York University and an Associate Professor in the Department of Family and Community Medicine at the University of Toronto. He is co-author of Drugs of Choice: A Formulary for General Practice and author of Drug Therapy for Emergency Physicians.

Posted: April 03, 2014